OptimizeRx Corporation
OPRX
$9.20
-$0.79-7.91%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 51.65% | 13.27% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 51.65% | 13.27% | |||
| Cost of Revenue | 30.92% | 10.61% | |||
| Gross Profit | 63.78% | 14.89% | |||
| SG&A Expenses | 28.83% | -6.64% | |||
| Depreciation & Amortization | -0.09% | 2.05% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 28.15% | -0.79% | |||
| Operating Income | 438.68% | 71.38% | |||
| Income Before Tax | 122.21% | -95.07% | |||
| Income Tax Expenses | 379.80% | 24.91% | |||
| Earnings from Continuing Operations | 99.15% | -127.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 99.15% | -127.64% | |||
| EBIT | 438.68% | 71.38% | |||
| EBITDA | 3,990.91% | 95.30% | |||
| EPS Basic | 99.16% | -126.83% | |||
| Normalized Basic EPS | 189.59% | 52.06% | |||
| EPS Diluted | 99.16% | -127.27% | |||
| Normalized Diluted EPS | 189.59% | 52.06% | |||
| Average Basic Shares Outstanding | 0.52% | 0.36% | |||
| Average Diluted Shares Outstanding | 0.52% | 0.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||